Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 974

1.

Orbital neuroblastoma metastasis: A case report and literature review.

Yang WJ, Zhou YY, Zhao F, Mei ZM, Li S, Xiang Y.

Medicine (Baltimore). 2019 Sep;98(36):e17038. doi: 10.1097/MD.0000000000017038. Review.

2.

Current management of neuroblastoma and future direction.

Pastor ER, Mousa SA.

Crit Rev Oncol Hematol. 2019 Jun;138:38-43. doi: 10.1016/j.critrevonc.2019.03.013. Epub 2019 Apr 1. Review.

PMID:
31092383
3.

Neuroblastoma in a Developing Country: Miles to Go.

Meena JP, Gupta AK.

Indian J Pediatr. 2019 May;86(5):403-405. doi: 10.1007/s12098-019-02930-7. Epub 2019 Mar 26. Review. No abstract available.

PMID:
30915646
4.

Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation.

Nunes-Xavier CE, Zaldumbide L, Aurtenetxe O, López-Almaraz R, López JI, Pulido R.

Int J Mol Sci. 2019 Mar 7;20(5). pii: E1170. doi: 10.3390/ijms20051170. Review.

5.

Targeting anaplastic lymphoma kinase in neuroblastoma.

Umapathy G, Mendoza-Garcia P, Hallberg B, Palmer RH.

APMIS. 2019 May;127(5):288-302. doi: 10.1111/apm.12940. Epub 2019 Apr 3. Review.

6.

Neuroblastoma with an unusual ovarian metastasis in a 5-year-old girl.

Steytler C, Darwish AA, Popov S, Morley-Jacob C, Aronson DC.

BMJ Case Rep. 2019 Feb 15;12(2). pii: e226038. doi: 10.1136/bcr-2018-226038. Review.

PMID:
30772831
7.

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma.

Morandi F, Frassoni F, Ponzoni M, Brignole C.

J Immunol Res. 2018 Oct 30;2018:8097398. doi: 10.1155/2018/8097398. eCollection 2018. Review.

8.

The challenge of defining "ultra-high-risk" neuroblastoma.

Morgenstern DA, Bagatell R, Cohn SL, Hogarty MD, Maris JM, Moreno L, Park JR, Pearson AD, Schleiermacher G, Valteau-Couanet D, London WB, Irwin MS.

Pediatr Blood Cancer. 2019 Apr;66(4):e27556. doi: 10.1002/pbc.27556. Epub 2018 Nov 26. Review.

PMID:
30479064
9.

CAR T Cell Therapy for Neuroblastoma.

Richards RM, Sotillo E, Majzner RG.

Front Immunol. 2018 Oct 16;9:2380. doi: 10.3389/fimmu.2018.02380. eCollection 2018. Review.

10.

The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma.

Greenwood KL, Foster JH.

Expert Opin Drug Saf. 2018 Dec;17(12):1257-1262. doi: 10.1080/14740338.2018.1549221. Epub 2018 Nov 28. Review.

PMID:
30433831
11.

Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma.

Pacenta HL, Macy ME.

Drug Des Devel Ther. 2018 Oct 23;12:3549-3561. doi: 10.2147/DDDT.S147384. eCollection 2018. Review.

12.

Endoscopic management of Esthesioneuroblastoma: Our experience and review of the literature.

Klironomos G, Gonen L, Au K, Monteiro E, Mansouri A, Turel MK, Witterick I, Vescan A, Zadeh G, Gentili F.

J Clin Neurosci. 2018 Dec;58:117-123. doi: 10.1016/j.jocn.2018.09.011. Epub 2018 Oct 16. Review.

PMID:
30340976
13.

Update on neuroblastoma.

Newman EA, Abdessalam S, Aldrink JH, Austin M, Heaton TE, Bruny J, Ehrlich P, Dasgupta R, Baertschiger RM, Lautz TB, Rhee DS, Langham MR Jr, Malek MM, Meyers RL, Nathan JD, Weil BR, Polites S, Madonna MB; APSA Cancer committee.

J Pediatr Surg. 2019 Mar;54(3):383-389. doi: 10.1016/j.jpedsurg.2018.09.004. Epub 2018 Sep 19. Review.

PMID:
30305231
14.

Testis Involvement in Neuroblastoma: Report of 3 Cases in the Turkish Pediatric Oncology Group-Neuroblastoma Study and Review of the Literature.

Kebudi R, Koc BS, Akici F, Cakir FB, Gorgun O, Olgun N.

J Pediatr Hematol Oncol. 2019 Jan;41(1):13-16. doi: 10.1097/MPH.0000000000001316. Review.

PMID:
30273225
15.

Advances in the Surgical Treatment of Neuroblastoma.

Luo YB, Cui XC, Yang L, Zhang D, Wang JX.

Chin Med J (Engl). 2018 Oct 5;131(19):2332-2337. doi: 10.4103/0366-6999.241803. Review.

16.

Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease.

Kroiss AS.

Wien Med Wochenschr. 2019 Feb;169(1-2):25-32. doi: 10.1007/s10354-018-0658-7. Epub 2018 Sep 4. Review.

PMID:
30182289
17.

Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.

Kholodenko IV, Kalinovsky DV, Doronin II, Deyev SM, Kholodenko RV.

J Immunol Res. 2018 Jul 11;2018:7394268. doi: 10.1155/2018/7394268. eCollection 2018. Review.

18.

The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma.

Ribatti D, Tamma R.

J Cell Physiol. 2018 Jan;234(1):152-157. doi: 10.1002/jcp.26773. Epub 2018 Aug 5. Review.

PMID:
30078179
19.

A review of neuroblastoma image-defined risk factors on magnetic resonance imaging.

Chen AM, Trout AT, Towbin AJ.

Pediatr Radiol. 2018 Aug;48(9):1337-1347. doi: 10.1007/s00247-018-4117-9. Epub 2018 Aug 4. Review.

PMID:
30078048
20.

Staging and following common pediatric malignancies: MRI versus CT versus functional imaging.

Voss SD.

Pediatr Radiol. 2018 Aug;48(9):1324-1336. doi: 10.1007/s00247-018-4162-4. Epub 2018 Aug 4. Review.

PMID:
30078040

Supplemental Content

Loading ...
Support Center